Elena Ivanova

ORCID: 0000-0002-5069-4974
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • interferon and immune responses
  • Cytokine Signaling Pathways and Interactions
  • Epigenetics and DNA Methylation
  • Cancer Immunotherapy and Biomarkers
  • Cancer Cells and Metastasis
  • Reproductive Biology and Fertility
  • Lung Cancer Treatments and Mutations
  • CAR-T cell therapy research
  • Cancer Research and Treatments
  • Lung Cancer Research Studies
  • MicroRNA in disease regulation
  • Cancer Genomics and Diagnostics
  • RNA modifications and cancer
  • Cancer Mechanisms and Therapy
  • Melanoma and MAPK Pathways
  • Genetic Syndromes and Imprinting
  • HER2/EGFR in Cancer Research
  • Cancer-related molecular mechanisms research
  • PI3K/AKT/mTOR signaling in cancer
  • Peptidase Inhibition and Analysis
  • Immune cells in cancer
  • Neuroblastoma Research and Treatments
  • Telomeres, Telomerase, and Senescence
  • Monoclonal and Polyclonal Antibodies Research
  • DNA Repair Mechanisms

Dana-Farber Cancer Institute
2015-2024

Ministry of Health
2024

BeiGene (China)
2019-2024

Babraham Institute
2011-2023

Barts Health NHS Trust
2023

St Bartholomew's Hospital
2023

Paul Ehrlich Institut
2023

Russian Academy of Sciences
2022

Institute of Cellular and Intracellular Symbiosis
2021

Massachusetts General Hospital
2003-2018

Whole-genome sequencing of 25 metastatic melanomas and matched germline DNA in humans reveals that the highest mutation load is associated with chronic sun exposure, PREX2 gene mutated approximately 14 per cent cases Melanoma a highly cancer, characterized by high lethality rapid development resistance to treatment. rate varies widely, exposure sunlight. — PTEN-interacting protein previously implicated breast cancer 14% cases. Although precise role melanoma remains be elucidated, ectopic...

10.1038/nature11071 article EN cc-by-nc-sa Nature 2012-05-01

Immune checkpoint blockade, exemplified by antibodies targeting the PD-1 receptor, can induce durable tumor regressions in some patients. To enhance efficacy of existing immunotherapies, we screened for small molecules capable increasing activity T cells suppressed PD-1. Here, show that short-term exposure to small-molecule inhibitors cyclin-dependent kinases 4 and 6 (CDK4/6) significantly enhances T-cell activation, contributing antitumor effects vivo, due part derepression NFAT family...

10.1158/2159-8290.cd-17-0915 article EN Cancer Discovery 2017-11-04

The Alternative Lengthening of Telomeres (ALT) pathway is a telomerase-independent for telomere maintenance that active in significant subset human cancers and vitro immortalized cell lines. ALT thought to involve templated extension telomeres through homologous recombination, but the genetic or epigenetic changes unleash are not known. Recently, mutations ATRX/DAXX chromatin remodeling complex histone H3.3 were found correlate with features pancreatic neuroendocrine cancers, pediatric...

10.1371/journal.pgen.1002772 article EN cc-by PLoS Genetics 2012-07-19

Ex vivo systems that incorporate features of the tumor microenvironment and model dynamic response to immune checkpoint blockade (ICB) may facilitate efforts in precision immuno-oncology development effective combination therapies. Here, we demonstrate ability interrogate ex ICB using murine- patient-derived organotypic spheroids (MDOTS/PDOTS). MDOTS/PDOTS isolated from mouse human tumors retain autologous lymphoid myeloid cell populations respond short-term three-dimensional microfluidic...

10.1158/2159-8290.cd-17-0833 article EN Cancer Discovery 2017-11-04

Multiple myeloma (MM) evolves from a highly prevalent premalignant condition termed MGUS. The factors underlying the malignant transformation of MGUS are unknown. We report MGUS/MM phenotype in transgenic mice with Eμ-directed expression XBP-1 spliced isoform (XBP-1s), factor governing unfolded protein/ER stress response and plasma-cell development. Eμ-XBP-1s elicited elevated serum Ig skin alterations. With age, Eμ-xbp-1s transgenics develop features diagnostic human MM, including bone...

10.1016/j.ccr.2007.02.015 article EN cc-by Cancer Cell 2007-04-01

Abstract KRAS-driven lung cancers frequently inactivate TP53 and/or STK11/LKB1, defining tumor subclasses with emerging clinical relevance. Specifically, KRAS-LKB1 (KL)–mutant are particularly aggressive, lack PD-L1, and respond poorly to immune checkpoint blockade (ICB). The mechanistic basis for this impaired immunogenicity, despite the overall high mutational load of KRAS-mutant cancers, remains obscure. Here, we report that LKB1 loss results in marked silencing stimulator interferon...

10.1158/2159-8290.cd-18-0689 article EN Cancer Discovery 2018-10-08
Michael Parfenov Chandra Sekhar Pedamallu Nils Gehlenborg Samuel S. Freeman Ludmila Danilova and 95 more Christopher A. Bristow Semin Lee Angela Hadjipanayis Elena Ivanova Matthew D. Wilkerson Alexei Protopopov Lixing Yang Sahil Seth Xingzhi Song Jiabin Tang Xiaojia Ren Jianhua Zhang Angeliki Pantazi Netty Santoso Andrew Wei Xu Harshad S. Mahadeshwar David A. Wheeler Robert I. Haddad Joonil Jung Akinyemi I. Ojesina Natalia Issaeva Wendell G. Yarbrough D. Neil Hayes Jennifer R. Grandis Adel K. El‐Naggar Matthew Meyerson Peter J. Park Lynda Chin Jonathan G. Seidman Peter S. Hammerman Raju Kucherlapati Adrian Ally Miruna Balasundaram İnanç Birol Reanne Bowlby Yaron S.N. Butterfield Rebecca Carlsen Dean Cheng Andy Chu Noreen Dhalla Ranabir Guin Robert A. Holt Steven J.M. Jones Darlene Lee Haiyan I. Li Marco A. Marra Michael Mayo Richard A. Moore Andrew J. Mungall A. Gordon Robertson Jacqueline E. Schein Payal Sipahimalani Angela Tam Nina Thiessen Tina Wong Alexei Protopopov Netty Santoso Semin Lee Michael Parfenov Jianhua Zhang Harshad S. Mahadeshwar Jiabin Tang Xiaojia Ren Sahil Seth Psalm Haseley Dong Zeng Lixing Yang Andrew Wei Xu Xingzhi Song Angeliki Pantazi Christopher A. Bristow Angela Hadjipanayis Jonathan G. Seidman Lynda Chin Peter J. Park Raju Kucherlapati Rehan Akbani Tod D. Casasent Wenbin Liu Yiling Lu Gordon B. Mills Thomas Motter John N. Weinstein Lixia Diao Jing Wang You Hong Fan Jinze Liu Kai Wang J. Todd Auman Saianand Balu Tom Bodenheimer Elizabeth Buda D. Neil Hayes Katherine A. Hoadley Alan P. Hoyle

Significance A significant proportion of head and neck cancer is driven by human papillomavirus (HPV) infection, the expression viral oncogenes involved in development these tumors. However, role HPV integration primary tumors beyond increasing oncoproteins not understood. Here, we describe how impacts host genome amplification disruption tumor suppressors as well driving inter- intrachromosomal rearrangements. Tumors that do have integrants display distinct gene profiles DNA methylation...

10.1073/pnas.1416074111 article EN Proceedings of the National Academy of Sciences 2014-10-13

Abstract The clinical efficacy of epidermal growth factor receptor (EGFR) kinase inhibitors is limited by the development drug resistance. irreversible EGFR inhibitor WZ4002 effective against most common mechanism resistance mediated T790M mutation. Here, we show, in multiple complementary models, that to develops through aberrant activation extracellular signal-regulated (ERK) signaling caused either an amplification mitogen-activated protein 1 (MAPK1) or downregulation negative regulators...

10.1158/2159-8290.cd-12-0103 article EN Cancer Discovery 2012-09-08

The 'expanded' HD CAG repeat that causes Huntington's disease (HD) encodes a polyglutamine tract in huntingtin, which first targets the death of medium-sized spiny striatal neurons. Mitochondrial energetics, related to N-methyl-d-aspartate (NMDA) Ca2+-signaling, has long been implicated this neuronal specificity, implying an integral role for huntingtin mitochondrial energy metabolism. As genetic test hypothesis, we have looked relationship between length repeat, expressed endogenous and ATP...

10.1093/hmg/ddi319 article EN Human Molecular Genetics 2005-08-22

Pancreas ductal adenocarcinoma (PDAC) is a highly lethal cancer that typically presents as advanced, unresectable disease. This invasive tendency, coupled with intrinsic resistance to standard therapies and genome instability, are major contributors poor long-term survival. The genetic elements governing the propensity of PDAC have not been well elucidated. Here, in course validating resident genes recurrent focal amplifications PDAC, we identified Rio Kinase 3 (RIOK3) an amplified gene...

10.1073/pnas.0809966105 article EN Proceedings of the National Academy of Sciences 2008-12-03

The number of children born since the origin Assisted Reproductive Technologies (ART) exceeds 5 million. majority seem healthy, but a higher frequency defects has been reported among ART-conceived infants, suggesting an epigenetic cost. We report first whole-genome DNA methylation datasets from single pig blastocysts showing differences between in vivo and vitro produced embryos. Blastocysts were either without (C-IVF) or presence natural reproductive fluids (Natur-IVF). Natur-IVF embryos...

10.7554/elife.23670 article EN cc-by eLife 2017-01-30

BACKGROUND. Immune checkpoint blockade improves survival in a subset of patients with non-small-cell lung cancer (NSCLC), but robust biomarkers that predict response to PD-1 pathway inhibitors are lacking. Furthermore, our understanding the diversity NSCLC tumor immune microenvironment remains limited. METHODS. We performed comprehensive flow cytometric immunoprofiling on both and cells from 51 NSCLCs integrated this analysis clinical histopathologic characteristics, next-generation...

10.1172/jci.insight.89014 article EN JCI Insight 2016-09-07
Coming Soon ...